The 60th anniversary of the British Nuclear Medicine Society (BNMS) marks a landmark moment in the evolution of nuclear medicine in the United Kingdom. Founded in 1966 at the Prince Alfred Pub, Queensway, London, the BNMS emerged from the pioneering spirit of four clinicians who recognised the transformative potential of radionuclide imaging and therapy. From these beginnings, the Society has grown into a vibrant multiprofessional community, uniting clinicians, scientists, physicists, radiopharmacists, technologists, radiographers, nurses, innovators, and researchers who continue to shape national standards, advance research and education, and champion excellence in patient care. This anniversary celebration reflects on the Society's rich heritage, but it also highlights the rapid technological and scientific advances that have redefined the field, from the early days of rectilinear scanners to state-of-the-art multimodal and new-generation gamma and positron emission tomography (PET) systems, including single photon emission computed tomography-computed tomography (SPECT-CT), PET-CT, PET-magnetic resonance imaging (PET-MRI), and the expanding landscape of theranostics. Through national platforms such as the BNMS Research Champions Network, the Molecular Radiotherapy Consortium, the National PET Imaging Platform, and our professional standards activities, the Society continues to drive excellence across the United Kingdom. Looking forward, the BNMS remains committed to innovation, inclusivity, and the continued integration of nuclear medicine within the wider healthcare system. Achieving this vision requires sustained investment in workforce development, infrastructure, and strong government engagement. The 60th Anniversary is both a celebration of past achievements and a call to seize the opportunities ahead, ensuring the UK remains a global leader in diagnostic and therapeutic nuclear medicine.
McCready et al. (Thu,) studied this question.